Neupro
- Product NDC
- 50474-801
- 11-digit product format
- 504740801
- Labeler code
- 50474
- Product ID
- 50474-801_385797e6-a44d-f4af-e063-6294a90a178a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rotigotine
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- UCB, Inc.
- Application
- NDA021829
- Marketing category
- NDA
- Marketing start
- 2012-04-02
- Substance
- ROTIGOTINE
- Active strength
- 1 mg/24h
- Pharmacologic classes
- Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021829-001 | NEUPRO | ROTIGOTINE | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | |
| N021829-002 | NEUPRO | ROTIGOTINE | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | |
| N021829-003 | NEUPRO | ROTIGOTINE | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | |
| N021829-004 | NEUPRO | ROTIGOTINE | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | |
| N021829-005 | NEUPRO | ROTIGOTINE | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | |
| N021829-006 | NEUPRO | ROTIGOTINE | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N021829-001 | 8246979 | 2027-09-01 | U-1272 | Drug product | 2012-09-11 |
| N021829-001 | 8246979 | 2027-09-01 | U-1273 | Drug product | 2012-09-11 |
| N021829-001 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | |
| N021829-001 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | |
| N021829-001 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | |
| N021829-002 | 8246979 | 2027-09-01 | U-1272 | Drug product | |
| N021829-002 | 8246979 | 2027-09-01 | U-1273 | Drug product | |
| N021829-002 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | |
| N021829-002 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | |
| N021829-002 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | |
| N021829-003 | 8246979 | 2027-09-01 | U-1272 | Drug product | |
| N021829-003 | 8246979 | 2027-09-01 | U-1273 | Drug product | |
| N021829-003 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | |
| N021829-003 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | |
| N021829-003 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | |
| N021829-004 | 8246979 | 2027-09-01 | U-1272 | Drug product | |
| N021829-004 | 8246979 | 2027-09-01 | U-1273 | Drug product | |
| N021829-004 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | |
| N021829-004 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | |
| N021829-004 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | |
| N021829-005 | 8246979 | 2027-09-01 | U-1272 | Drug product | |
| N021829-005 | 8246979 | 2027-09-01 | U-1273 | Drug product | |
| N021829-005 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | |
| N021829-005 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | |
| N021829-005 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | |
| N021829-006 | 8246979 | 2027-09-01 | U-1272 | Drug product | |
| N021829-006 | 8246979 | 2027-09-01 | U-1273 | Drug product | |
| N021829-006 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | |
| N021829-006 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | |
| N021829-006 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-005 | NEUPRO | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-006 | NEUPRO | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-005 | NEUPRO | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-006 | NEUPRO | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021829-005 | NEUPRO | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021829-006 | NEUPRO | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021829-005 | NEUPRO | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021829-006 | NEUPRO | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021829-005 | NEUPRO | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021829-006 | NEUPRO | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021829-005 | NEUPRO | 3MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021829-006 | NEUPRO | 8MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021829-001 | NEUPRO | 2MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD, RS | 2007-05-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021829-002 | NEUPRO | 4MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021829-003 | NEUPRO | 6MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2007-05-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021829-004 | NEUPRO | 1MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | RLD | 2012-04-02 | 2680178bc6a6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021829-001 | 8246979 | 2027-09-01 | U-1272 | Drug product | 2012-09-11 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-001 | 8246979 | 2027-09-01 | U-1273 | Drug product | 2012-09-11 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-001 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-001 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-001 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-002 | 8246979 | 2027-09-01 | U-1272 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-002 | 8246979 | 2027-09-01 | U-1273 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-002 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-002 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-002 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-003 | 8246979 | 2027-09-01 | U-1272 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-003 | 8246979 | 2027-09-01 | U-1273 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-003 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-003 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-003 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-004 | 8246979 | 2027-09-01 | U-1272 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-004 | 8246979 | 2027-09-01 | U-1273 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-004 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-004 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-004 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-005 | 8246979 | 2027-09-01 | U-1273 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-005 | 8246979 | 2027-09-01 | U-1272 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-005 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-005 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-005 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-006 | 8246979 | 2027-09-01 | U-1273 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-006 | 8246979 | 2027-09-01 | U-1272 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-006 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-006 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021829-006 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | 8246980 | 2025-11-27 | Drug product | 2012-09-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | 8246979 | 2027-09-01 | U-1272 | Drug product | 2012-09-11 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | 8246979 | 2027-09-01 | U-1273 | Drug product | 2012-09-11 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | 10350174 | 2030-12-22 | Drug product | 2019-07-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-001 | 9925150 | 2032-03-01 | Drug product | 2018-04-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-002 | 8246980 | 2025-11-27 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-002 | 8246979 | 2027-09-01 | U-1272 | Drug product | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-002 | 8246979 | 2027-09-01 | U-1273 | Drug product | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021829-002 | 10130589 | 2030-12-22 | Drug product | 2018-11-30 | 31067a03dcf5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neupro
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ROTIGOTINE | 1 mg/24h |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 87T4T8BO2E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 722253 | Internal RxNorm lookup |
| 722256 | Internal RxNorm lookup |
| 722279 | Internal RxNorm lookup |
| 722295 | Internal RxNorm lookup |
| 724142 | Internal RxNorm lookup |
| 724156 | Internal RxNorm lookup |
| 1251912 | Internal RxNorm lookup |
| 1251914 | Internal RxNorm lookup |
| 1251916 | Internal RxNorm lookup |
| 1251918 | Internal RxNorm lookup |
| 1251920 | Internal RxNorm lookup |
| 1251922 | Internal RxNorm lookup |
| 1360632 | Internal RxNorm lookup |
| 1360633 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50474-801-03 | Neupro | 30 in 1 CARTON | PATCH, EXTENDED RELEASE | 30 | 20 | |
| 50474-801-03 | Neupro | 1 in 1 POUCH | PATCH, EXTENDED RELEASE | 1 | 20 | |
| 50474-801-17 | Neupro | 1 in 1 POUCH | PATCH, EXTENDED RELEASE | 1 | 20 | |
| 50474-801-17 | Neupro | 7 in 1 CARTON | PATCH, EXTENDED RELEASE | 7 | 20 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50474-801-03 | EA - Each | 50474-801 | 678ac746-88a5-4249-b925-8866efbbdcc1 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| rotigotine | ACTIVE INGREDIENT | 87T4T8BO2E | NEUPRO (ROTIGOTINE) PATCH, EXTENDED RELEASE NEUPRO (ROTIGOTINE) KIT [UCB, INC.] | 9 | |
| rotigotine | ACTIVE MOIETY | 87T4T8BO2E | NEUPRO (ROTIGOTINE) PATCH, EXTENDED RELEASE NEUPRO (ROTIGOTINE) KIT [UCB, INC.] | 9 | |
| .alpha.-tocopherol, dl- | INACTIVE INGREDIENT | 7QWA1RIO01 | NEUPRO (ROTIGOTINE) PATCH, EXTENDED RELEASE NEUPRO (ROTIGOTINE) KIT [UCB, INC.] | 9 | |
| ascorbyl palmitate | INACTIVE INGREDIENT | QN83US2B0N | NEUPRO (ROTIGOTINE) PATCH, EXTENDED RELEASE NEUPRO (ROTIGOTINE) KIT [UCB, INC.] | 9 | |
| povidones | INACTIVE INGREDIENT | FZ989GH94E | NEUPRO (ROTIGOTINE) PATCH, EXTENDED RELEASE NEUPRO (ROTIGOTINE) KIT [UCB, INC.] | 9 | |
| sodium metabisulfite | INACTIVE INGREDIENT | 4VON5FNS3C | NEUPRO (ROTIGOTINE) PATCH, EXTENDED RELEASE NEUPRO (ROTIGOTINE) KIT [UCB, INC.] | 9 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neupro | ROTIGOTINE | UCB, Inc. | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 2025-06-24 | Warnings, Adverse reactions | 021829 NDA021829 50474-801 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1360633 | {7 (24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro]) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System [Neupro]) } Pack [Neupro Kit] | BPCK | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1360632 | {7 (24 HR rotigotine 0.0833 MG/HR Transdermal System) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System) } Pack | GPCK | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251914 | Neupro 1 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722256 | Neupro 2 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251918 | Neupro 3 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724142 | Neupro 4 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724156 | Neupro 6 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251922 | Neupro 8 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1360633 | Neupro Titration Kit for Parkinson's disease Pack | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722253 | rotigotine 2 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1360632 | rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722295 | rotigotine 4 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722279 | rotigotine 6 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | PSN | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251914 | 24 HR rotigotine 0.0417 MG/HR Transdermal System [Neupro] | SBD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722256 | 24 HR rotigotine 0.0833 MG/HR Transdermal System [Neupro] | SBD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251918 | 24 HR rotigotine 0.125 MG/HR Transdermal System [Neupro] | SBD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724142 | 24 HR rotigotine 0.167 MG/HR Transdermal System [Neupro] | SBD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724156 | 24 HR rotigotine 0.25 MG/HR Transdermal System [Neupro] | SBD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251922 | 24 HR rotigotine 0.333 MG/HR Transdermal System [Neupro] | SBD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251912 | 24 HR rotigotine 0.0417 MG/HR Transdermal System | SCD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722253 | 24 HR rotigotine 0.0833 MG/HR Transdermal System | SCD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251916 | 24 HR rotigotine 0.125 MG/HR Transdermal System | SCD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722295 | 24 HR rotigotine 0.167 MG/HR Transdermal System | SCD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722279 | 24 HR rotigotine 0.25 MG/HR Transdermal System | SCD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251920 | 24 HR rotigotine 0.333 MG/HR Transdermal System | SCD | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251914 | 24 HR Neupro 0.0417 MG/HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722256 | 24 HR Neupro 0.0833 MG/HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251918 | 24 HR Neupro 0.125 MG/HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724142 | 24 HR Neupro 0.167 MG/HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724156 | 24 HR Neupro 0.25 MG/HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251922 | 24 HR Neupro 0.333 MG/HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251914 | Neupro 1 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251914 | Neupro 1 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722256 | Neupro 2 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722256 | Neupro 2 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251918 | Neupro 3 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251918 | Neupro 3 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724142 | Neupro 4 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724142 | Neupro 4 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724156 | Neupro 6 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 724156 | Neupro 6 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251922 | Neupro 8 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251922 | Neupro 8 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1360633 | Neupro Titration Kit for Parkinson's disease | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251912 | rotigotine 0.0417 MG/HR 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722253 | rotigotine 0.0833 MG/HR 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251916 | rotigotine 0.125 MG/HR 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722295 | rotigotine 0.167 MG/HR 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722279 | rotigotine 0.25 MG/HR 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251920 | rotigotine 0.333 MG/HR 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251912 | rotigotine 1 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251912 | rotigotine 1 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722253 | rotigotine 2 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722253 | rotigotine 2 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251916 | rotigotine 3 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251916 | rotigotine 3 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722295 | rotigotine 4 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722295 | rotigotine 4 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722279 | rotigotine 6 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 722279 | rotigotine 6 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251920 | rotigotine 8 MG/Day 24 HR Transdermal Patch | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
| 1251920 | rotigotine 8 MG/Day 24HR Transdermal System | SY | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | 20 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50474-801-03 | 50474080103 | 30 POUCH in 1 CARTON (50474-801-03) / 1 PATCH in 1 POUCH / 24 h in 1 PATCH | 30 pouch | 2012-04-02 | 0000-00-00 | No | No | Current |
| 50474-801-17 | 50474080117 | 7 POUCH in 1 CARTON (50474-801-17) / 1 PATCH in 1 POUCH / 24 h in 1 PATCH | 7 pouch | 2012-04-02 | 0000-00-00 | No | No | Current |